Loading…

Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro

Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST...

Full description

Saved in:
Bibliographic Details
Published in:Microcirculation (New York, N.Y. 1994) N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a
Main Authors: Piao, Jiyuan, Hong, Hyun Sook, Son, Youngsook
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43
cites cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43
container_end_page n/a
container_issue 3
container_start_page e12443
container_title Microcirculation (New York, N.Y. 1994)
container_volume 25
creator Piao, Jiyuan
Hong, Hyun Sook
Son, Youngsook
description Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis. Results TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP. Conclusions SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.
doi_str_mv 10.1111/micc.12443
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999194323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1999194323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</originalsourceid><addsrcrecordid>eNp9kc9uFDEMxiMEoqVw4QFQJC6o0pYkk8lMjmhFS6VCkQrnKJNx2lQzyZI_bfdWiRfgGXkSMmzhwAFfbMk_f7L9IfSSkiNa4-3sjDmijPPmEdqnLZervqPyca1J16yk6Ps99Cyla0JI3zP5FO0xySsv5T76flGGlLU3gD9jPcPkQtQZEs5lDhF7MDEkl7DVJof48_6HnjZXumbnx2JgxODHkK_qnJ6wgWnC4zbZ4k12weNhiyNclkln5y8xfDq_wHC3iZDS0nUe37gcw3P0xOopwYuHfIC-Hr__sv6wOjs_OV2_O1uZpq2H8Fb0hoMYupYYLfqRDZSCkFa2grdSdNYya3qmSauNFVrzznaSE9sOHEbgzQF6s9PdxPCtQMpqdmnZWXsIJSkqpaSSN6yp6Ot_0OtQoq_bKUZYIyTtBKvU4Y5anpQiWLWJbtZxqyhRizVqsUb9tqbCrx4kyzDD-Bf940UF6A64dRNs_yOlPp6u1zvRX7yCnVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2023691762</pqid></control><display><type>article</type><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</creator><creatorcontrib>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</creatorcontrib><description>Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis. Results TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP. Conclusions SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</description><identifier>ISSN: 1073-9688</identifier><identifier>EISSN: 1549-8719</identifier><identifier>DOI: 10.1111/micc.12443</identifier><identifier>PMID: 29412499</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Apoptosis ; Endothelium ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - pathology ; Endothelium, Vascular - physiopathology ; Human Umbilical Vein Endothelial Cells ; Humans ; inflammation ; Inflammation - chemically induced ; Inflammation - drug therapy ; Necrosis ; Neurotransmitter Agents - therapeutic use ; nitric oxide ; Nitric Oxide - biosynthesis ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - drug effects ; Nitric Oxide Synthase Type III - metabolism ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction - drug effects ; substance P ; Substance P - pharmacology ; Substance P - therapeutic use ; Tumor Necrosis Factor-alpha - adverse effects ; Tumor necrosis factor-TNF ; vascular endothelium</subject><ispartof>Microcirculation (New York, N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a</ispartof><rights>2018 John Wiley &amp; Sons Ltd</rights><rights>2018 John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2018 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</citedby><cites>FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</cites><orcidid>0000-0003-3659-1386 ; 0000-0003-1656-0056</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29412499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piao, Jiyuan</creatorcontrib><creatorcontrib>Hong, Hyun Sook</creatorcontrib><creatorcontrib>Son, Youngsook</creatorcontrib><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><title>Microcirculation (New York, N.Y. 1994)</title><addtitle>Microcirculation</addtitle><description>Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis. Results TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP. Conclusions SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</description><subject>Apoptosis</subject><subject>Endothelium</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Human Umbilical Vein Endothelial Cells</subject><subject>Humans</subject><subject>inflammation</subject><subject>Inflammation - chemically induced</subject><subject>Inflammation - drug therapy</subject><subject>Necrosis</subject><subject>Neurotransmitter Agents - therapeutic use</subject><subject>nitric oxide</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - drug effects</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>substance P</subject><subject>Substance P - pharmacology</subject><subject>Substance P - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - adverse effects</subject><subject>Tumor necrosis factor-TNF</subject><subject>vascular endothelium</subject><issn>1073-9688</issn><issn>1549-8719</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc9uFDEMxiMEoqVw4QFQJC6o0pYkk8lMjmhFS6VCkQrnKJNx2lQzyZI_bfdWiRfgGXkSMmzhwAFfbMk_f7L9IfSSkiNa4-3sjDmijPPmEdqnLZervqPyca1J16yk6Ps99Cyla0JI3zP5FO0xySsv5T76flGGlLU3gD9jPcPkQtQZEs5lDhF7MDEkl7DVJof48_6HnjZXumbnx2JgxODHkK_qnJ6wgWnC4zbZ4k12weNhiyNclkln5y8xfDq_wHC3iZDS0nUe37gcw3P0xOopwYuHfIC-Hr__sv6wOjs_OV2_O1uZpq2H8Fb0hoMYupYYLfqRDZSCkFa2grdSdNYya3qmSauNFVrzznaSE9sOHEbgzQF6s9PdxPCtQMpqdmnZWXsIJSkqpaSSN6yp6Ot_0OtQoq_bKUZYIyTtBKvU4Y5anpQiWLWJbtZxqyhRizVqsUb9tqbCrx4kyzDD-Bf940UF6A64dRNs_yOlPp6u1zvRX7yCnVU</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Piao, Jiyuan</creator><creator>Hong, Hyun Sook</creator><creator>Son, Youngsook</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3659-1386</orcidid><orcidid>https://orcid.org/0000-0003-1656-0056</orcidid></search><sort><creationdate>201804</creationdate><title>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</title><author>Piao, Jiyuan ; Hong, Hyun Sook ; Son, Youngsook</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Endothelium</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Human Umbilical Vein Endothelial Cells</topic><topic>Humans</topic><topic>inflammation</topic><topic>Inflammation - chemically induced</topic><topic>Inflammation - drug therapy</topic><topic>Necrosis</topic><topic>Neurotransmitter Agents - therapeutic use</topic><topic>nitric oxide</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - drug effects</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>substance P</topic><topic>Substance P - pharmacology</topic><topic>Substance P - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - adverse effects</topic><topic>Tumor necrosis factor-TNF</topic><topic>vascular endothelium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piao, Jiyuan</creatorcontrib><creatorcontrib>Hong, Hyun Sook</creatorcontrib><creatorcontrib>Son, Youngsook</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Microcirculation (New York, N.Y. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piao, Jiyuan</au><au>Hong, Hyun Sook</au><au>Son, Youngsook</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro</atitle><jtitle>Microcirculation (New York, N.Y. 1994)</jtitle><addtitle>Microcirculation</addtitle><date>2018-04</date><risdate>2018</risdate><volume>25</volume><issue>3</issue><spage>e12443</spage><epage>n/a</epage><pages>e12443-n/a</pages><issn>1073-9688</issn><eissn>1549-8719</eissn><abstract>Objective The aim of this study was to explore the beneficial effects of SP on NO production and inflammation‐induced vascular endothelium cell death. Methods To mimic the inflammatory environment, TNF‐α was treated with HUVECs, and SP was added prior to TNF‐α to determine its protective effect. WST‐1 assay was performed to detect cell viability. NO level in conditioned medium was measured by Griess Reagent System. The protein level of cleaved caspase‐3, eNOS, and phosphorylated Akt was detected by Western blot analysis. Results TNF‐α declined endothelial cell viability by downregulating Akt and NO production. TNF‐α‐induced cell death was reliably restored by NO, confirming the requirement of NO for cell survival. By contrast, pretreatment of SP attenuated TNF‐α‐induced cellular apoptosis, accompanied by an increase in the phosphorylation of Akt, eNOS expression, and NO production. Blockage of NK‐1R, phosphorylated Akt or eNOS by CP‐96345, A6730, or L‐NAME entirely eliminated the effect of SP. Conclusions SP can protect the vascular endothelium against inflammation‐induced damage through modulation of the Akt/eNOS/NO signaling pathway.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29412499</pmid><doi>10.1111/micc.12443</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3659-1386</orcidid><orcidid>https://orcid.org/0000-0003-1656-0056</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1073-9688
ispartof Microcirculation (New York, N.Y. 1994), 2018-04, Vol.25 (3), p.e12443-n/a
issn 1073-9688
1549-8719
language eng
recordid cdi_proquest_miscellaneous_1999194323
source Wiley-Blackwell Read & Publish Collection
subjects Apoptosis
Endothelium
Endothelium, Vascular - drug effects
Endothelium, Vascular - pathology
Endothelium, Vascular - physiopathology
Human Umbilical Vein Endothelial Cells
Humans
inflammation
Inflammation - chemically induced
Inflammation - drug therapy
Necrosis
Neurotransmitter Agents - therapeutic use
nitric oxide
Nitric Oxide - biosynthesis
Nitric Oxide - metabolism
Nitric Oxide Synthase Type III - drug effects
Nitric Oxide Synthase Type III - metabolism
Proto-Oncogene Proteins c-akt - metabolism
Signal Transduction - drug effects
substance P
Substance P - pharmacology
Substance P - therapeutic use
Tumor Necrosis Factor-alpha - adverse effects
Tumor necrosis factor-TNF
vascular endothelium
title Substance P ameliorates tumor necrosis factor‐alpha‐induced endothelial cell dysfunction by regulating eNOS expression in vitro
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A16%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substance%20P%20ameliorates%20tumor%20necrosis%20factor%E2%80%90alpha%E2%80%90induced%20endothelial%20cell%20dysfunction%20by%20regulating%20eNOS%20expression%20in%20vitro&rft.jtitle=Microcirculation%20(New%20York,%20N.Y.%201994)&rft.au=Piao,%20Jiyuan&rft.date=2018-04&rft.volume=25&rft.issue=3&rft.spage=e12443&rft.epage=n/a&rft.pages=e12443-n/a&rft.issn=1073-9688&rft.eissn=1549-8719&rft_id=info:doi/10.1111/micc.12443&rft_dat=%3Cproquest_cross%3E1999194323%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3573-4568c4e6b750ca68d2b11e69f95645967ff2fc82a05acf6aa47f7940f5b4ede43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2023691762&rft_id=info:pmid/29412499&rfr_iscdi=true